136 related articles for article (PubMed ID: 33012675)
21. Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention.
Park H; Kim HK; Jeong MH; Cho JY; Lee KH; Sim DS; Yoon NS; Yoon HJ; Hong YJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kim YJ; Cho MC; Kim CJ;
J Cardiol; 2017 Jan; 69(1):216-221. PubMed ID: 27141820
[TBL] [Abstract][Full Text] [Related]
22. Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents.
Sarno G; Räber L; Onuma Y; Garg S; Brugaletta S; van Domburg RT; Pilgrim T; Pfäffli N; Wenaweser P; Windecker S; Serruys P
Am J Cardiol; 2011 Jul; 108(2):195-201. PubMed ID: 21529741
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D and prognosis in acute myocardial infarction.
Ng LL; Sandhu JK; Squire IB; Davies JE; Jones DJ
Int J Cardiol; 2013 Oct; 168(3):2341-6. PubMed ID: 23415169
[TBL] [Abstract][Full Text] [Related]
24. [Outcome of patients with coronary artery disease and left ventricular ejection fraction less than 50% undergoing percutaneous coronary intervention].
Jiang L; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Gao LJ; Song L; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1058-1066. PubMed ID: 29325366
[No Abstract] [Full Text] [Related]
25. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2019 Jan; 280():166-173. PubMed ID: 30529829
[TBL] [Abstract][Full Text] [Related]
26. Body Mass Index and Sudden Cardiac Death in Japanese Patients After Acute Myocardial Infarction: Data From the JCAD Study and HIJAMI-II Registry.
Shiga T; Kohro T; Yamasaki H; Aonuma K; Suzuki A; Ogawa H; Hagiwara N; Yamazaki T; Nagai R; Kasanuki H
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982233
[TBL] [Abstract][Full Text] [Related]
27. Underweight Predicts Greater Risk of Cardiac Mortality Post Acute Myocardial Infarction.
Su W; Wang M; Zhu J; Li W; Ding X; Chen H; Li HW; Zhao XQ
Int Heart J; 2020 Jul; 61(4):658-664. PubMed ID: 32641636
[TBL] [Abstract][Full Text] [Related]
28. BMI, Infarct Size, and Clinical Outcomes Following Primary PCI: Patient-Level Analysis From 6 Randomized Trials.
Shahim B; Redfors B; Chen S; Thiele H; Eitel I; Gkargkoulas F; Crowley A; Ben-Yehuda O; Maehara A; Stone GW
JACC Cardiovasc Interv; 2020 Apr; 13(8):965-972. PubMed ID: 32327093
[TBL] [Abstract][Full Text] [Related]
29. Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.
Galea N; Dacquino GM; Ammendola RM; Coco S; Agati L; De Luca L; Carbone I; Fedele F; Catalano C; Francone M
Eur Radiol; 2019 May; 29(5):2369-2377. PubMed ID: 30552479
[TBL] [Abstract][Full Text] [Related]
30. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI;
Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396
[TBL] [Abstract][Full Text] [Related]
31. The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.
Her AY; Choi BG; Rha SW; Kim YH; Choi CU; Jeong MH
PLoS One; 2020; 15(11):e0242314. PubMed ID: 33253206
[TBL] [Abstract][Full Text] [Related]
32. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death.
Nigam A; Wright RS; Allison TG; Williams BA; Kopecky SL; Reeder GS; Murphy JG; Jaffe AS
Int J Cardiol; 2006 Jun; 110(2):153-9. PubMed ID: 16043245
[TBL] [Abstract][Full Text] [Related]
33. Relationship of obesity to adverse events in myocardial infarction patients without primary percutaneous coronary intervention: results from the Occluded Artery Trial (OAT).
Xing Z; Pei J; Huang J; Hu X; Gao S
Curr Med Res Opin; 2019 Sep; 35(9):1563-1569. PubMed ID: 30950656
[No Abstract] [Full Text] [Related]
34. Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
Kang WY; Jeong MH; Ahn YK; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
J Cardiol; 2010 Jan; 55(1):84-91. PubMed ID: 20122553
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Clinical Outcomes Between Ticagrelor and Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction - Results From the Korea Acute Myocardial Infarction Registry-National Institutes of Health.
Kim MC; Jeong MH; Sim DS; Hong YJ; Kim JH; Ahn Y; Ahn TH; Seung KB; Choi DJ; Kim HS; Gwon HC; Seong IW; Hwang KK; Chae SC; Hur SH; Cha KS; Oh SK; Chae JK;
Circ J; 2018 Jun; 82(7):1866-1873. PubMed ID: 29643279
[TBL] [Abstract][Full Text] [Related]
36. Impact of obesity on the outcome of Chinese patients with ST-segment myocardial infarction undergoing urgent percutaneous coronary intervention.
Sun Y; Jiang D; Zhang B; Yu H; Gao Y; Li Y; Qi G
Acta Cardiol; 2012 Oct; 67(5):541-8. PubMed ID: 23252004
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
38. Two-year clinical outcomes of zotarolimus- and everolimus-eluting durable-polymer-coated stents versus biolimus-eluting biodegradable-polymer-coated stent in patients with acute myocardial infarction with dyslipidemia after percutaneous coronary intervention: data from the KAMIR.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Heart Vessels; 2019 Feb; 34(2):237-250. PubMed ID: 30167772
[TBL] [Abstract][Full Text] [Related]
39. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
[TBL] [Abstract][Full Text] [Related]
40. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization.
Kim MC; Jeong MH; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Cho SY; Rha SW; Bae JH; Cho JG; Park SJ;
Int J Cardiol; 2011 Dec; 153(2):148-53. PubMed ID: 20843572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
